Integer Holdings stock gains 5.18 percent after KKR deal

Published on 09/29/2026 at 21:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Integer Holdings stock posted adjusted EPS of USD 1.60 in Q2 2026 against USD 1.38 consensus. KKR agreed to pay USD 127.00 per share in its proposed takeover.

ITGR, US45826J1051, Illustration mit AI erstellt.

Integer Holdings Corporation (ISIN US45826J1051) was trading at EUR 10.56 at Lang & Schwarz on September 29, 2026 at 9:13 p.m. CEST, up 5.18 percent versus the prior close of EUR 10.04. The move came as investors weighed a proposed KKR takeover against weaker second-quarter revenue and rising leverage.

KKR sets a USD 127.00 value

According to Yahoo Finance on September 29, 2026, Integer entered a definitive agreement on August 2, 2026, to be acquired by KKR affiliates for USD 127.00 in cash per eligible share. The deal requires shareholder approval and regulatory clearances, while completion would take Integer private and end its NYSE listing.

The offer creates a defined transaction value, but the current US listing remains below that consideration. Integer was trading at USD 126.37 on the NYSE on September 29, 2026 at 3:15 p.m. ET, while its 52-week range stood at USD 62.00 to USD 126.80.

Q2 revenue fell 2.60 percent

MarketBeat reported on September 28, 2026, that Integer delivered USD 1.60 in adjusted EPS for the second quarter of 2026, beating the USD 1.38 consensus by USD 0.22. Revenue reached USD 464.11 million, down 2.60 percent from the year-earlier quarter and above the USD 451.07 million estimate.

The operating split explains the mixed result. Cardio and Vascular sales fell 2.00 percent to USD 280.30 million, while Cardiac Rhythm Management and Neuromodulation revenue rose 1.00 percent to USD 173.70 million, according to Yahoo Finance on September 29, 2026.

Leverage becomes the key risk

S&P Global Ratings downgraded Integer to B from BB- on September 8, 2026, after identifying a planned USD 2.10 billion first-lien term loan and USD 3.80 billion of sponsor equity for the transaction. The agency expects adjusted leverage to reach the mid-6x area in 2026, compared with 4x as of July 3, 2026.

That financing structure is the main counterweight to the cash offer. Integer's investor-relations page identifies the company as a medical device contract development and manufacturing organization serving cardio and vascular, neuromodulation, and cardiac rhythm management markets.

Integer Holdings stock gains 5.18 percent

Integer Holdings stock was trading at EUR 10.56 at Lang & Schwarz on September 29, 2026 at 9:13 p.m. CEST, up 5.18 percent versus the Lang & Schwarz prior close of EUR 10.04 on September 28, 2026.